| __timestamp | Geron Corporation | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 20707000 | 1488000000 |
| Thursday, January 1, 2015 | 17831000 | 1525000000 |
| Friday, January 1, 2016 | 18047000 | 2111000000 |
| Sunday, January 1, 2017 | 11033000 | 1848000000 |
| Monday, January 1, 2018 | 13432000 | 1213000000 |
| Tuesday, January 1, 2019 | 52072000 | 1010000000 |
| Wednesday, January 1, 2020 | 51488000 | 997000000 |
| Friday, January 1, 2021 | 85727000 | 967000000 |
| Saturday, January 1, 2022 | 95518000 | 838000000 |
| Sunday, January 1, 2023 | 125046000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
Unleashing insights
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Teva Pharmaceutical Industries Limited and Geron Corporation have taken distinct paths in their R&D investments.
Teva has consistently allocated substantial resources to R&D, with an average annual expenditure of approximately $1.3 billion. Despite a slight decline in recent years, Teva's investment remains robust, underscoring its commitment to innovation.
In contrast, Geron Corporation has shown a remarkable increase in R&D spending, growing by over 500% from 2014 to 2023. This surge reflects Geron's strategic focus on advancing its pipeline, particularly in the field of oncology.
These contrasting strategies highlight the diverse approaches companies take in navigating the pharmaceutical landscape, each aiming to secure a competitive edge through innovation.
Comparing Innovation Spending: Eli Lilly and Company and Geron Corporation
AbbVie Inc. vs Teva Pharmaceutical Industries Limited: Strategic Focus on R&D Spending
R&D Insights: How Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited Allocate Funds
Teva Pharmaceutical Industries Limited or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
Teva Pharmaceutical Industries Limited or Bio-Techne Corporation: Who Invests More in Innovation?
R&D Spending Showdown: Teva Pharmaceutical Industries Limited vs PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Madrigal Pharmaceuticals, Inc. and Geron Corporation
Who Prioritizes Innovation? R&D Spending Compared for Vericel Corporation and Geron Corporation
Geron Corporation or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Geron Corporation vs Galapagos NV